Vinge advised Nordea Bank Abp and Citigroup Global Markets Limited which are acting as Global Coordinators and Bookrunners in connection with a directed share issue of SEK 312 million in Better Collective A/S through an accelerated book building procedure.
Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with an investment by a number of investors of in total USD 85 million in Voi Technology AB, a company that provides an electric scooter sharing service.
Vinge has advised Nextmune and its U.S. subsidiary Spectrum Veterinary, LLC, in connection with the acquisition of U.S. veterinary allergy testing and treatment activities from ALK.
Vinge has advised Gränges AB (publ) in connection with the acquisition of Aluminium Konin, a Polish aluminium manufacturer, for SEK 2.3 billion from Boryszew Group. In connection with the transaction, Gränges intends to perform a rights issue for SEK 2 billion. In order to finance the acquisition, Gränges has entered into a bridge financing facility agreement with certain Nordic banks for SEK 2.3 billion.
Vinge represented the sellers Meritor, Inc. Retirement Plan, Sunrise BE I, LLC and YRC Worldwide, Inc. Master Pension Plans Trust in their divestment of shares in Solör Bioenergi Holding AB (”Solör”) to Polhem Infra KB (”Polhem”).
On 7 November 2019, Vonovia SE announced, through its indirectly wholly-owned subsidiary HomeStar InvestCo AB, a mandatory cash offer to the shareholders of Hembla AB (publ) to acquire all shares in Hembla.
Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) has announced a recommended public offer to the shareholders of Hemfosa Fastigheter AB (publ) (“Hemfosa”) to tender all their shares in Hemfosa to SBB.
Vinge has advised Skandinaviska Enskilda Banken AB (publ) as to Swedish law in connection with the issuance of Additional Tier 1 Capital (AT1) of USD 900 million to optimise its capital structure.
Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 125 million in issue proceeds.
Vinge has acted as a Swedish local counsel to Krogerus in advising Caverion Oyj, one of the Europe's leading provider of technical solutions for buildings and industries, on its acquisition of Huurre Finland Oy, including its subsidiary Huurre Sweden AB.
